Core Viewpoint - The company, Demingli (001309.SZ), announced adjustments to its fundraising projects to optimize internal resources and improve operational efficiency without changing the total investment amount or terminating any projects [1] Group 1: Project Adjustments - The investment amount for the "PCIe SSD storage controller chip and storage module R&D and industrialization project" will increase from 498.5614 million to 743.3595 million [1] - The investment amount for the "embedded storage controller chip and storage module R&D and industrialization project" will decrease from 666.8090 million to 340.4756 million [1] - The implementation locations for both projects will now include Guangming District, Shenzhen [1] Group 2: Project Scope - The adjustments will not affect the "information system upgrade construction project" or the "supplementary working capital project" [1]

Core Viewpoint - The company, Demingli (001309.SZ), announced adjustments to its fundraising projects to optimize internal resources and improve operational efficiency while maintaining the total investment amount and project implementation主体 [1] Investment Project Adjustments - The investment amount for the "PCIe SSD storage controller chip and storage module R&D and industrialization project" will increase from 498.5614 million to 743.3595 million [1] - The investment amount for the "embedded storage controller chip and storage module R&D and industrialization project" will decrease from 666.8090 million to 340.4756 million [1] - The implementation locations for both projects will now include Guangming District, Shenzhen [1] Project Exclusions - The adjustments do not affect the "Information System Upgrade Construction Project" and the "Supplementary Working Capital Project" [1]

德明利公告，拟调整2023年向特定对象发行股票募投项目"PCIe SSD存储控制芯片及存储模组的研发和 产业化项目"和"嵌入式存储控制芯片及存储模组的研发和产业化项目"的投资总额、内部投资结构及增 加项目实施地点。其中，"PCIe SSD存储控制芯片及存储模组的研发和产业化项目"投资总额将从4.99亿 元调整为7.43亿元，"嵌入式存储控制芯片及存储模组的研发和产业化项目"投资总额将从6.67亿元调整 为3.4亿元。此次调整旨在优化资源配置，提高经营管理效率及募集资金使用效率。 ...

Core Viewpoint - The company, Zhejiang Tianzhen Technology Co., Ltd., is undergoing significant changes in its fundraising projects and operational strategies due to external trade pressures and internal performance challenges [1][3][8]. Summary by Relevant Sections Company Operations and Fundraising Projects - The company has extended the construction period of its fundraising project in the U.S. to June 30, 2027, changing the project from an annual production capacity of 3 million square meters to 2 million square meters of new inorganic composite flooring [1][2][4]. - The U.S. project is now managed by a new entity, Boson New Materials Company, located in Georgia, with construction expected to start in December 2024 and production to begin in July 2025 [1][2][4]. Performance and Challenges - The company has faced significant challenges due to U.S. customs imposing strict import restrictions, which have severely impacted export orders and overall business performance [2][3][8]. - As of 2024, the company is projected to incur losses, prompting it to enhance research and development efforts and explore new product lines to stabilize its operations [3][8]. Compliance and Regulatory Actions - The company has been reminded to continuously monitor factors leading to performance fluctuations and to fulfill its information disclosure obligations [2][3][10]. - Due to the improper use of idle fundraising capital, the company and its executives received warnings from regulatory bodies, necessitating a comprehensive review and improvement of internal controls related to fundraising management [9][10].

Core Viewpoint - The report details the usage of previously raised funds by Fujian Wancheng Biotechnology Group Co., Ltd., highlighting the financial management and adjustments made to investment projects to enhance operational efficiency and market competitiveness [2][12][14]. Fundraising Overview - The company raised a net amount of RMB 228.60 million from its initial public offering (IPO) after deducting issuance costs [2]. - In a subsequent issuance to specific investors, the company raised RMB 200 million, with a net amount of RMB 193.60 million after expenses [3]. Fund Usage and Management - As of June 30, 2025, the company had utilized RMB 162.59 million from the IPO funds and RMB 142.49 million from the specific issuance funds [4][5]. - The company established special accounts for managing the raised funds, ensuring compliance with regulatory requirements and protecting investor interests [9][10]. Project Adjustments - The company changed the investment project from "Annual Production of 21,000 Tons of Shimeji Mushroom" to "Annual Production of 53,000 Tons of Enoki Mushroom," aiming to improve market competitiveness and reduce production costs [12][14]. - The adjusted investment amount for the new project is RMB 100 million, with a total planned investment of RMB 470.57 million [14]. Financial Performance - As of June 30, 2025, the project for producing 53,000 tons of Enoki mushrooms reported a cumulative loss of RMB 51.39 million, indicating challenges in the edible mushroom business due to market conditions [16].

Summary of Key Points Core Viewpoint The report provides an overview of the fundraising activities and the utilization of raised funds by Hainan Huluwa Pharmaceutical Group Co., Ltd. for the first half of 2025, highlighting the total amount raised, expenses incurred, and the allocation of funds to various projects. Fundraising Basic Situation - The company raised a total of RMB 208,119,000.00 by issuing 40,100,000 shares at RMB 5.19 per share, with net proceeds amounting to RMB 173,119,000.00 after deducting underwriting fees of RMB 35,000,000.00 [1][2]. - The funds were deposited into a regulatory account managed by the lead underwriter, CITIC Securities Co., Ltd. [1]. Fundraising Usage and Balance - As of June 30, 2025, the total amount of raised funds was RMB 208,119,000.00, with total expenses of RMB 57,079,347.77, resulting in a net amount of RMB 151,039,652.23 [2]. - The remaining balance of the raised funds at the end of the period was RMB 11,878,482.50 after accounting for various expenditures and interest income [2][4]. Fund Management and Storage - The company established a dedicated account for the management of raised funds, adhering to relevant regulations and guidelines to ensure proper usage and protection of investor interests [2][3]. - A tripartite supervision agreement was signed with the banks and the underwriter to clarify the rights and obligations of all parties involved [2][3]. Project Adjustments and Fund Allocation - The company adjusted the implementation of the "Marketing System Construction and Brand Promotion Project" to be managed by its wholly-owned subsidiary, Hainan Huluwa Pharmaceutical Co., Ltd. [3]. - The company decided to reallocate funds from the "Pediatric Drug Research Project" to other urgent drug research projects due to delays in the original project [10][11]. Financial Performance and Future Outlook - The company reported that the fundraising projects do not directly generate economic benefits, making it challenging to assess their individual performance [6][11]. - The long-term benefits of the drug research projects are expected to enhance the company's core competitiveness and market presence [6][7]. Compliance and Disclosure - The company confirmed compliance with all relevant laws and regulations regarding the use of raised funds and timely disclosure of information [12][13]. - There were no violations in the use of raised funds, and all disclosed information accurately reflects the company's financial activities [12].

Meeting Overview - The second meeting of the Supervisory Board of Jiangsu Hengshang Energy Saving Technology Co., Ltd. was held on August 28, 2025, with all three supervisors present, complying with legal and regulatory requirements [1][2]. Financial Report Review - The Supervisory Board approved the 2025 Half-Year Report and its summary, confirming that it accurately reflects the company's financial status and operational results [1][2]. Fund Utilization Report - The Supervisory Board approved the special report on the storage and actual use of raised funds for the first half of 2025, with unanimous support from all supervisors [2][3]. Investment Structure Adjustment - The Supervisory Board approved the adjustment of the internal investment structure for certain fundraising projects, stating that the decision was made prudently based on the implementation status of the projects and the company's operational development, ensuring no harm to shareholder interests [2][3].

Core Viewpoint - The company has approved an adjustment to the internal investment structure of its fundraising project for the "Semiconductor Testing Equipment Intelligent Manufacturing and Innovation R&D Center Phase I" without changing the total investment amount or the direction of the raised funds [1][4]. Fundraising Basic Situation - The company raised a total of RMB 878.7 million by issuing 15 million shares at a price of RMB 58.58 per share in February 2023, with the funds received after deducting issuance costs [1]. - The funds are stored in a dedicated account, and a regulatory agreement has been signed with the bank and sponsor [1]. Fundraising Usage Situation - As of June 30, 2025, the cumulative investment in the semiconductor testing equipment project was RMB 74.68 million, with RMB 49.53 million already utilized [2]. - The project for producing 1,000 sets of semiconductor testing sorting machines has been terminated due to slower-than-expected progress influenced by external economic factors [3]. Adjustment of Internal Investment Structure - The adjustment is based on the evolving needs of the company as it continues to upgrade its products and respond to industry trends, ensuring efficient use of raised funds [4][5]. - The total investment amount for the project remains unchanged, with a focus on optimizing resource allocation [5]. Impact of the Adjustment - The adjustment is seen as a prudent decision that will not affect the normal implementation of the fundraising project and aligns with the company's long-term interests [5][6]. - The company aims to enhance the efficiency of fund usage and ensure the successful implementation of the investment project [5]. Review Procedures and Opinions - The adjustment has been reviewed and approved by the company's board and supervisory committee, following necessary approval procedures [6]. - The supervisory committee and sponsor have expressed no objections to the adjustment, confirming compliance with relevant regulations [6].

Group 1 - The company announced the termination of the "Tianyuan Logistics Warehouse Construction Project" due to delays in fundraising and changes in the macro and market environment [1] - The company has re-evaluated the necessity and feasibility of its fundraising projects, leading to the modification of the "Huzhou Tianyuan Technology Upgrade Project" and "Hangzhou Hongwang Production Base Construction Project" to the "Tianyuan Pet Vietnam Pet Cage Project" [1] - These changes have impacted the progress of fundraising utilization, and the company will actively coordinate resources to improve the efficiency of fundraising usage and ensure the smooth implementation of subsequent projects [1] Group 2 - The company plans to manage idle fundraising through cash management to enhance cash asset returns while ensuring the safety of the funds and meeting project funding needs [1] - This approach aims to effectively reduce financial costs and improve the overall efficiency of capital utilization [1]

Core Viewpoint - Guokai Co., Ltd. (688103.SH) announced a significant adjustment in its fundraising project for the production of wind-solar storage and flexible direct current transmission and distribution contactors, reducing the planned investment from 200 million yuan to 57.5 million yuan due to changes in market conditions [1] Company Summary - The project has not yet received any of the planned fundraising, with 0 million yuan invested so far, representing 0% of the total planned investment [1] - The remaining 142.5 million yuan of the fundraising will be redirected to a new project focused on the expansion of high-end electronic vacuum devices and integrated system intelligent manufacturing [1] Industry Summary - The primary reason for the adjustment is the lower-than-expected growth in demand for upstream photovoltaic supporting equipment, coupled with intensified competition in the industry, which has led to continuous pressure on the pricing and gross margin of the company's contactor products [1]